← Open Payments lookup

NICOLE ZUBER: Open Payments

NPI 1407017932 · NEWARK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$925 in 57 payments from 9 companies in 2025. Trend: 2023 $427 · 2024 $870 · 2025 $925

Food & beverage: $925
CompanyPaymentsAmount
Alkermes, Inc.19$300
Janssen Pharmaceuticals, Inc13$199
Teva Pharmaceuticals USA, Inc.10$160
Lundbeck LLC6$105
Otsuka America Pharmaceutical, Inc.3$54
E.R. Squibb & Sons, L.L.C.2$38
Neurocrine BioSciences, Inc.2$34
Axsome Therapeutics, Inc.1$18
Tris Pharma Inc1$17

Products named: ARISTADA, INVEGA SUSTENNA, UZEDY, ABILIFY ASIMTUFII, COBENFY, REXULTI, ABILIFY MAINTENA, INGREZZA.

Industry payments across NJ — which companies pay providers there.